BeiGene Ltd (HK:6160) has released an update.
BeiGene, Ltd., a biotechnology company, is set to hold an audit committee meeting on August 26, 2024, to approve and publish its interim financial results for the first half of the year. The results to be discussed have already been filed with the U.S. SEC and will include additional information required by the Hong Kong Listing Rules. This meeting follows a previous announcement and filing of their interim results for the same period.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.
